Position in HUMA
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$64,428
+$20,360 QoQ
Shares Held
82,600
+13.8% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#55
of 163 holders
Holding Since
Mar 2022
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HUMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kovack Advisors, Inc. holds $5,014,818 across 13 Biotechnology names. HUMA ranks #12 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZVRA |
Zevra Therapeutics, Inc.
|
171,151 | $2,454,305 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,315 | $653,199 | |
| 3 | MRNA |
Moderna, Inc.
|
3,995 | $279,769 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,675 | $273,714 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
4,936 | $269,209 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
392 | $244,427 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
921 | $221,933 | |
| 8 | IBRX |
ImmunityBio, Inc.
|
20,808 | $182,174 |
All Filings in HUMA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,428 | 82,600 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $44,068 | 72,600 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $69,768 | 72,600 | Shares | Sole | 2026-02-17 | |
| 2023-09-30 | $123,060 | 42,000 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $114,400 | 40,000 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $108,150 | 35,000 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $52,750 | 25,000 | Shares | Sole | 2023-02-22 | |
| 2022-03-31 | $222,390 | 31,500 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||